About CSL Biotherapies
Reliability — Safety — Quality — Heritage
CSL Biotherapies understands the influenza vaccine business and customers’ needs for reliable and safe flu vaccine supplies. Our long-established parent, CSL Limited, has been producing flu vaccine without disruption for nearly four decades. Based in Melbourne, Australia, CSL provides flu vaccine to Australia, New Zealand, and more than 16 countries in Europe, South America and Asia.
Beginning with the 2007-2008 season, CSL Biotherapies has been contributing to meeting the growing demand in the United States for reliable supplies of flu vaccine each year. CSL Biotherapies is ideally positioned to become a reliable resource for healthcare professionals who actively embrace the United States government’s flu immunization recommendations.
Millions of people outside the United States already rely on CSL for their flu vaccine. CSL Biotherapies offers several competitive advantages to health care professionals in search of timely delivery of high-quality flu vaccines.
Download the CSL Biotherapies Brochure (.pdf)